Cargando…

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

Numerous clinical and population studies have demonstrated that increased serum bilirubin levels protect against cardiovascular and metabolic diseases such as obesity and diabetes. Bilirubin is a potent antioxidant, and the beneficial actions of moderate increases in plasma bilirubin have been thoug...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stec, David E., John, Kezia, Trabbic, Christopher J., Luniwal, Amarjit, Hankins, Michael W., Baum, Justin, Hinds, Terry D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829185/ https://www.ncbi.nlm.nih.gov/pubmed/27071062 http://dx.doi.org/10.1371/journal.pone.0153427

Ejemplares similares

Timcodar (VX-853) Is a Non-FKBP12 Binding Macrolide Derivative That Inhibits PPARγ and Suppresses Adipogenesis
por: Hinds, Terry D., et al.
Publicado: (2016)

Cutting edge concepts: Does bilirubin enhance exercise performance?
por: Flack, Kyle D., et al.
Publicado: (2023)

Bilirubin, a new therapeutic for kidney transplant?
por: Sundararaghavan, Vikram L., et al.
Publicado: (2018)

PPARα: A Master Regulator of Bilirubin Homeostasis
por: Bigo, Cyril, et al.
Publicado: (2014)

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate
por: Hinds, Terry D., et al.
Publicado: (2020)

Reactive Oxygen Species (ROS) and Antioxidants as Immunomodulators in Exercise: Implications for Heme Oxygenase and Bilirubin
por: Thomas, David Travis, et al.
Publicado: (2022)

Identification of Binding Regions of Bilirubin in the Ligand-Binding Pocket of the Peroxisome Proliferator-Activated Receptor-A (PPARalpha)
por: Gordon, Darren M., et al.
Publicado: (2021)

Neobavaisoflavone Induces Bilirubin Metabolizing Enzyme UGT1A1 via PPARα and PPARγ
por: Zhu, Ya-Di, et al.
Publicado: (2021)

Bilirubin Nanoparticle Treatment in Obese Mice Inhibits Hepatic Ceramide Production and Remodels Liver Fat Content
por: Kipp, Zachary A., et al.
Publicado: (2023)

Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue
por: Hinds, Terry D., et al.
Publicado: (2021)

The marine‐derived furanone reduces intracellular lipid accumulation in vitro by targeting LXRα and PPARα
por: Li, Ting, et al.
Publicado: (2020)

Suppressing Hepatic UGT1A1 Increases Plasma Bilirubin, Lowers Plasma Urobilin, Reorganizes Kinase Signaling Pathways and Lipid Species and Improves Fatty Liver Disease
por: Bates, Evelyn A., et al.
Publicado: (2023)

Rats Genetically Selected for High Aerobic Exercise Capacity Have Elevated Plasma Bilirubin by Upregulation of Hepatic Biliverdin Reductase-A (BVRA) and Suppression of UGT1A1
por: Hinds, Terry D., et al.
Publicado: (2020)

Gemfibrozil reduces lipid accumulation in SMMC-7721 cells via the involvement of PPARα and SREBP1
por: Zhang, Xiaonan, et al.
Publicado: (2019)

PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017)

Bilirubin, Renal Hemodynamics, and Blood Pressure
por: Stec, David E., et al.
Publicado: (2012)

Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2
por: Hana, Claudia A., et al.
Publicado: (2021)

Accumulation of Lipid Droplets in a Novel Bietti Crystalline Dystrophy Zebrafish Model With Impaired PPARα Pathway
por: Gao, Pan, et al.
Publicado: (2022)

Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2019)

PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression
por: Ye, Guozhu, et al.
Publicado: (2019)

Bromide alleviates fatty acid‐induced lipid accumulation in mouse primary hepatocytes through the activation of PPARα signals
por: Shi, Yujie, et al.
Publicado: (2019)

ROS accumulation and IGF-IR inhibition contribute to fenofibrate/PPARα -mediated inhibition of Glioma cell motility in vitro
por: Drukala, Justyna, et al.
Publicado: (2010)

Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways
por: Badmus, Olufunto O., et al.
Publicado: (2022)

PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction
por: Yin, Xiaozhe, et al.
Publicado: (2020)

Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels
por: Liu, Jinfeng, et al.
Publicado: (2015)

Deciphering the Roles of Thiazolidinediones and PPARγ in Bladder Cancer
por: Chiu, Melody, et al.
Publicado: (2017)

PPARα is essential for retinal lipid metabolism and neuronal survival
por: Pearsall, Elizabeth A., et al.
Publicado: (2017)

Hepatic Lipid Catabolism via PPARα-Lysosomal Crosstalk
por: Sinha, Rohit A., et al.
Publicado: (2020)

ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway
por: Cao, Yanlin, et al.
Publicado: (2023)

Overexpression CPT1A reduces lipid accumulation via PPARα/CD36 axis to suppress the cell proliferation in ccRCC: CPT1A inhibits ccRCC cell proliferation via PPARα/CD36 axis
por: Yang, Hui, et al.
Publicado: (2021)

(+)-Dehydrovomifoliol Alleviates Oleic Acid-Induced Lipid Accumulation in HepG2 Cells via the PPARα–FGF21 Pathway
por: Xi, Yiyuan, et al.
Publicado: (2021)

Hif1α/Dhrs3a Pathway Participates in Lipid Droplet Accumulation via Retinol and Ppar-γ in Fish Hepatocytes
por: Tian, Jingjing, et al.
Publicado: (2023)

Berberine Reduces Lipid Accumulation in Obesity via Mediating Transcriptional Function of PPARδ
por: Shou, Jia-Wen, et al.
Publicado: (2023)

Heat-Killed Enterococcus faecalis Prevents Adipogenesis and High Fat Diet-Induced Obesity by Inhibition of Lipid Accumulation through Inhibiting C/EBP-α and PPAR-γ in the Insulin Signaling Pathway
por: Lee, Jin-Ho, et al.
Publicado: (2022)

Transcriptional Regulation of Human and Rat Hepatic Lipid Metabolism by the Grapefruit Flavonoid Naringenin: Role of PPARα, PPARγ and LXRα
por: Goldwasser, Jonathan, et al.
Publicado: (2010)

Role of PPARα and HNF4α in Stress-Mediated Alterations in Lipid Homeostasis
por: Konstandi, Maria, et al.
Publicado: (2013)

Corrigendum: Bilirubin Increases Insulin Sensitivity by Regulating Cholesterol Metabolism, Adipokines and PPARγ Levels
por: Liu, Jinfeng, et al.
Publicado: (2016)

Extract of Acalypha australis L. inhibits lipid accumulation and ameliorates HFD-induced obesity in mice through regulating adipose differentiation by decreasing PPARγ and CEBP/α expression
por: You, Lang, et al.
Publicado: (2021)

MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
por: Venkatesh, Divya, et al.
Publicado: (2020)

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6g0e7ohtda9pup388iuhc25f0q